Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Zucara

Zucara
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Debt LATEST DEAL TYPE
$3.9M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of a novel drug therapy designed to prevent hypoglycemia. The company's novel drug therapy helps to restore the body's ability to reduce occurrence of hypoglycemia and its associated acute symptoms and effects, enabling healthcare providers to more aggressively treat their patients with insulin, resulting in better overall health outcomes in the long term.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 1300-661 University Avenue
  • Toronto, Ontario M5G 0B7
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Zucara’s full profile, request a free trial.

Zucara Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Debt - General 09-Apr-2018 $3.9M 00.000 Completed Pre-Clinical Trials
5. Accelerator/Incubator 09-Feb-2018 00000 Completed Pre-Clinical Trials
4. Grant 08-Feb-2018 00000 00000 Completed Pre-Clinical Trials
3. Grant 21-Sep-2017 00000 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 03-Nov-2016 Cancelled Startup
1. Early Stage VC 03-Nov-2016 $525K $525K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Zucara Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator Minority 000 0000 000000 0
National Research Council Canada Government 000 0000 000000 0
Accel-Rx Accelerator/Incubator Minority 000 0000 000000 0
Centre for Drug Research and Development Corporation 000 0000 000000 0
Toronto Innovation Acceleration Partners Not-For-Profit Venture Capital Minority 000 0000 000000 0

Zucara Executive Team (5)

Name Title Board
Seat
Contact
Info
Michael Midmer Chief Executive Officer & Board Member
Richard Liggins Ph.D Co-Founder and Chief Scientific Officer
David Coy Ph.D Advisor
Mladen Vranic Ph.D Advisor

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Zucara Board Members (6)

Name Representing Role Since Contact
Info
Claude Piche Ph.D Self Board Member 000 0000
Jonathon Jafari Self Board Member 000 0000
Luc Mainville Self Chairman 000 0000
Michael Midmer Zucara Chief Executive Officer & Board Member 000 0000
Michael Riddell Ph.D Self Chairman of Clinical Advisory Board 000 0000
You’re viewing 5 of 6 board members. Get the full list »